Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

BioPharma Dive

11 biopharma execs & experts look back on 2015: A record year for record-breaking

11 biopharma execs & experts look back on 2015: A record year for record-breaking

  • December 22, 2015
  • min read

BioPharma Dive

11 biopharma execs & experts look back on 2015: A record year for record-breaking

BioPharma Dive asked top thought leaders to share what they considered to be the top biopharma "game-changers" of 2015. "A major game-changer in 2015 was increasing price pressure on prescription drugs in the U.S. market coming from a rapidly consolidating customer case (payers/PBMs, providers and channel)," said Ashish Singh, the leader of Bain & Company's Global Healthcare practice. "This trend is now starting to endanger the economic lifeblood of the global pharmaceutical industry—the premium price reimbursement in the U.S."